Krystal Biotech (KRYS) Inventory Average (2023 - 2026)

Krystal Biotech has disclosed Inventory Average across 4 years of filings, most recently posting $41.6 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $41.6 million, up 47.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.6 million (up 47.25% YoY), and the FY2025 annual result was $33.5 million, up 99.99% from the prior year.
• Inventory Average came in at $41.6 million for Q1 2026 at Krystal Biotech, up from $39.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $41.6 million in Q1 2026 to a low of $6.1 million in Q4 2023.
• The 4-year median for Inventory Average is $25.4 million (2024), against an average of $23.8 million.
• Across the five-year window, Inventory Average jumped 267.68% in 2024 and soared 47.25% in 2026, its largest moves.
• Krystal Biotech's Inventory Average stood at $6.1 million in 2023, then surged by 267.68% to $22.5 million in 2024, then soared by 73.23% to $39.1 million in 2025, then climbed by 6.42% to $41.6 million in 2026.
• The last three Inventory Average figures came in at $41.6 million (Q1 2026), $39.1 million (Q4 2025), and $34.3 million (Q3 2025), per Business Quant data.